Idrish Ali

Idrish Ali

Auto-generated profile, based on publicly available information

Idrish Ali

Department of Neuroscience, School of Translational Medicine Monash University Melbourne Victoria Australia

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2015 in Neurobiology of Disease
Verified
Journal Article
Open access
IAIdrish Ali
Idrish Ali
DCDeepti Chugh
Deepti Chugh
CEChristine T Ekdahl
Christine T Ekdahl
Temporal lobe seizures lead to an acute inflammatory response in the brain primarily characterized by activation of parenchymal microglial cells. Simultaneously, degeneration of pyramidal cells and interneurons is evident together with a seizure-induced increase in the production of new neurons within the dentate gyrus of the hippocampus. We have previously shown a negative correlation between the acute seizure-induced inflammation and the survival of newborn hippocampal neurons. Here, we aimed to evaluate the role of the fractalkine-CX3CR1 pathway for these acute events. Fractalkine is a chemokine expressed by both neurons and glia, while its receptor, CX3CR1 is primarily expressed on microglia. Electrically-induced partial status epilepticus (SE) was induced in adult rats through stereotaxically implanted electrodes in the hippocampus. Recombinant rat fractalkine or CX3CR1 antibody was infused intraventricularly during one week post-SE. A significant increase in the expression of CX3CR1, but not fractalkine, was observed in the dentate gyrus at one week. CX3CR1 antibody treatment resulted in a reduction in microglial activation, neurodegeneration, as well as neuroblast production. In contrast, fractalkine treatment had only minor effects. This study provides evidence for a role of the fractalkine-CX3CR1 signaling pathway in seizure-induced microglial activation and suggests that neuroblast production following seizures may partly occur as a result of microglial activation.

1 June 2016 in Neuropharmacology
Verified
Journal Article
Closed access
HAHalima Amhaoul
Halima Amhaoul
IAIdrish Ali
Idrish Ali
MMMarco Mola
Marco Mola
AEAnnemie Van Eetveldt
Annemie Van Eetveldt
KSKrystyna Szewczyk
Krystyna Szewczyk
SDStefanie Dedeurwaerdere
Stefanie Dedeurwaerdere

6 November 2017 in Frontiers in Neurology
Verified
Journal Article
Open access
DBDaniele Bertoglio
Daniele Bertoglio
HAHalima Amhaoul
Halima Amhaoul
AEAnnemie Van Eetveldt
Annemie Van Eetveldt
RHRuben Houbrechts
Ruben Houbrechts
SVSebastiaan Van De Vijver
Sebastiaan Van De Vijver
SDStefanie Dedeurwaerdere
Stefanie Dedeurwaerdere
The aim of epilepsy models is to investigate disease ontogenesis and therapeutic interventions in a consistent and prospective manner. The kainic acid (KA)-induced status epilepticus (SE) (KASE) rat model is a widely used, well-validated model for temporal lobe epilepsy (TLE). As we noted significant variability within the model between labs potentially related to the rat strain used, we aimed to describe two variants of this model with diverging seizure phenotype and neuropathology. In addition, we evaluated two different protocols to induce SE. Wistar Han (Charles River, France) and Sprague Dawley (Harlan, The Netherlands) rats were subjected to KASE using the Hellier KA and a modified injection scheme. Duration of SE and latent phase were characterized by video-electroencephalography (vEEG) in a subgroup of animals, while animals were sacrificed 1 week (subacute phase) and 12 weeks (chronic phase) post-SE. In the 12 weeks post-SE groups, seizures were monitored with vEEG. Neuronal loss (NeuN), microglial activation (OX-42 and translocator protein - TSPO), and neurodegeneration (FjC) were assessed. Firstly, the Hellier protocol caused very high mortality in WH/CR rats compared to SD/H animals. The modified protocol resulted in a similar SE severity for WH/CR and SD/H rats, but effectively improved survival rates. The latent phase was significantly shorter (p < 0.0001) in SD/H (median 8.3 days) animals compared to WH/CR (median 15.4 days). During the chronic phase, SD/H rats had more seizures/day compared to WH/CR animals (p < 0.01). However, neuronal degeneration and cell loss were overall more extensive in WH/CR than in SD/H rats; microglia activation was similar between the two strains 1 week post-SE, but higher in WH/CR rats 12 weeks post-SE. These neuropathological differences may be more related to the distinct neurotoxic effects of KA in the two rat strains than being the outcome of seizure burden itself. The divergences in disease progression and seizure outcome, in addition to the histopathological dissimilarities, further substantiate the existence of strain differences for the KASE rat model of TLE.

1 March 2019 in Neurobiology of Disease
Verified
Journal Article
Closed access
PSPatricia G. Saletti
Patricia G. Saletti
IAIdrish Ali
Idrish Ali
PCPablo M. Casillas-Espinosa
Pablo M. Casillas-Espinosa
BSBridgette D. Semple
Bridgette D. Semple
CLChristos Panagiotis Lisgaras
Christos Panagiotis Lisgaras
AGAristea Galanopoulou
Aristea Galanopoulou

13 January 2020 in Epilepsia
Verified
Journal Article
Closed access
PDF file
PTPeravina Therajaran
Peravina Therajaran
JHJohn A. Hamilton
John A. Hamilton
TOTerence J. O'Brien
Terence J. O'Brien
NJNigel Charles Jones
Nigel Charles Jones
IAIdrish Ali
Idrish Ali

1 March 2019 in Epilepsy Research
Verified
Journal Article
Closed access
XNXavier Ekolle Ndode-Ekane
Xavier Ekolle Ndode-Ekane
CSCesar Santana-Gomez
Cesar Santana-Gomez
PCPablo M. Casillas-Espinosa
Pablo M. Casillas-Espinosa
IAIdrish Ali
Idrish Ali
RBRhys D. Brady
Rhys D. Brady
APAsla Pitkänen
Asla Pitkänen